Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Endoscopy

Computer-aided quality assurance versus standard colonoscopy: a systematic review and meta-analysis of randomized controlled trials

6 affiliations
  1. 1Center for HR & Education CAMES Copenhagen Denmark
  2. 2Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark
  3. 3Department of Urology Zealand University Hospital Roskilde Roskilde Denmark
  4. 4Department of Anesthesiology and Intensive Care Lillebaelt Hospital - University Hospital of Southern Denmark Kolding Denmark
  5. 5Research Unit of Medical Education University of Southern Denmark Odense Denmark
  6. 6GastroUnit Copenhagen University Hospital - Amager and Hvidovre Hvidovre Denmark

Abstract

Background: Computer-aided quality assurance (CAQ) can provide feedback to improve mucosal inspection during colonoscopy. This systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated the efficacy of CAQ versus standard colonoscopy in enhancing colonoscopy quality indicators.

Methods: Adhering to PRISMA guidelines, we searched MEDLINE, Embase, and CENTRAL for RCTs comparing CAQ with standard colonoscopy. The primary outcome was adenoma detection rate (ADR). Secondary outcomes included detection rates for advanced adenoma (AADR) and adenocarcinoma (ACDR), adenomas per colonoscopy (APC), and withdrawal time. Pooled risk ratios (RRs) and weighted mean differences (WMDs) were calculated using random-effects models.

Results: Six RCTs involving 5687 colonoscopies (CAQ 2895; standard colonoscopy 2792) were included. Compared with standard colonoscopy, CAQ increased ADR by 43% (RR [95%CI]: 1.43 [1.17–1.73]; P < 0.001, I2 = 73.5%), with heterogeneity decreasing substantially after omitting one study (1.52 [1.32–1.75]; P < 0.001, I2 = 11.9%); AADR by 54% (1.54 [1.26–1.87]; P < 0.001, I2 = 0.0%); ACDR by 30% (1.30 [1.00–1.68]; P = 0.047, I2 = 0.0%); APC by 0.14 adenomas (WMD [95%CI]: 0.14 [0.08–0.20]; P < 0.001, I2 = 53.2%); adenomas ≥10 mm by 0.03 adenomas (0.03 [0.02–0.05]; P < 0.001, I2 = 45.1%); and withdrawal time increased by 0.64 minutes (0.64 [0.04–1.24]; P = 0.04, I2 = 96.1%).

Conclusions: CAQ significantly improved ADR and detection of clinically significant lesions. While findings for AADR and ACDR should be interpreted with caution due to low event rates, the improvements in detection of adenomas ≥10 mm and APC suggest that CAQ may lower the risk of post-colonoscopy colorectal cancer, a hypothesis that warrants evaluation in future long-term analyses of patient outcomes.

Related

  1. Total Colonic Decompression After Colonoscopy for the Prevention of Post-colonoscopy Abdominal Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Mohammed Karkaman, Basel Alasmari, Fatimah Ghaidan A. Almuawi +12
    CureusPeer-reviewedCC BYFull textOncologyEurope PMCEurope PMCPMC
  2. Effectiveness of artificial intelligence-assisted colonoscopy for colorectal lesion detection: a systematic review and meta-analysis of randomized controlled trials
    Xia Liu, Jian Qin, Yuxia Zhao +3
    BMC Medical ImagingPeer-reviewedCC BYFull textOncologyDOAJ
  3. Tocilizumab in Acute Coronary Syndromes: A Systematic Review of Randomized Controlled Trials
    Muhammad Umair Iqbal, Hassan Askari, Ira Abid +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Topical herbal medicine as treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized controlled trials
    Carrie Shao, Cassie Shao, Andrew Haggarty +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  5. Perioperative intravenous lidocaine for the prevention of chronic postsurgical pain: a systematic review and meta-analysis of randomized controlled trials
    Wei-Jing Zhu, Ran An, Qian-Yun Pang +1
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{cold2026computeraided,
  title = {{Computer-aided quality assurance versus standard colonoscopy: a systematic review and meta-analysis of randomized controlled trials}},
  author = {Kristoffer Mazanti Cold and Martine S. Nielsen and Juana Maria Abdelreda and Flemming Bjerrum and Lars Konge},
  journal = {Endoscopy},
  year = {2026},
  month = aug,
  doi = {10.1055/a-2904-8262},
  url = {https://doi.org/10.1055/a-2904-8262},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Computer-aided quality assurance versus standard colonoscopy: a systematic review and meta-analysis of randomized controlled trials
AU  - Kristoffer Mazanti Cold
AU  - Martine S. Nielsen
AU  - Juana Maria Abdelreda
AU  - Flemming Bjerrum
AU  - Lars Konge
PY  - 2026
DA  - 2026/08/06
JO  - Endoscopy
DO  - 10.1055/a-2904-8262
UR  - https://doi.org/10.1055/a-2904-8262
AB  - Background: Computer-aided quality assurance (CAQ) can provide feedback to improve mucosal inspection during colonoscopy. This systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated the efficacy of CAQ versus standard colonoscopy in enhancing colonoscopy quality indicators.  Methods: Adhering to PRISMA guidelines, we searched MEDLINE, Embase, and CENTRAL for RCTs comparing CAQ with standard colonoscopy. The primary outcome was adenoma detection rate (ADR). Secondary outcomes included detection rates for advanced adenoma (AADR) and adenocarcinoma (ACDR), adenomas per colonoscopy (APC), and withdrawal time. Pooled risk ratios (RRs) and weighted mean differences (WMDs) were calculated using random-effects models.  Results: Six RCTs involving 5687 colonoscopies (CAQ 2895; standard colonoscopy 2792) were included. Compared with standard colonoscopy, CAQ increased ADR by 43% (RR [95%CI]: 1.43 [1.17–1.73]; P < 0.001, I2 = 73.5%), with heterogeneity decreasing substantially after omitting one study (1.52 [1.32–1.75]; P < 0.001, I2 = 11.9%); AADR by 54% (1.54 [1.26–1.87]; P < 0.001, I2 = 0.0%); ACDR by 30% (1.30 [1.00–1.68]; P = 0.047, I2 = 0.0%); APC by 0.14 adenomas (WMD [95%CI]: 0.14 [0.08–0.20]; P < 0.001, I2 = 53.2%); adenomas ≥10 mm by 0.03 adenomas (0.03 [0.02–0.05]; P < 0.001, I2 = 45.1%); and withdrawal time increased by 0.64 minutes (0.64 [0.04–1.24]; P = 0.04, I2 = 96.1%).  Conclusions: CAQ significantly improved ADR and detection of clinically significant lesions. While findings for AADR and ACDR should be interpreted with caution due to low event rates, the improvements in detection of adenomas ≥10 mm and APC suggest that CAQ may lower the risk of post-colonoscopy colorectal cancer, a hypothesis that warrants evaluation in future long-term analyses of patient outcomes.
SN  - 0013-726X
SN  - 1438-8812
ER  -